Can We Beat Cancer? AI, mRNA, and the Future of Living Longer | Longevity, Episode 2

In the second episode of this four-part series, Rubenstein delved into the breakthroughs in cancer detection and treatment, how artificial intelligence could transform prevention and early diagnosis, why cancer rates are rising among young adults, the role of mRNA vaccines in preventing and treating future cancers and the urgent challenges of health disparities and access to care. Guests include: Dr. Selwyn M. Vickers | Memorial Sloan Kettering Cancer Center President & CEO Dr. Benjamin L. Ebert | Dana-Farber Cancer Institute President and CEO Dr. David Agus | Ellison Medical Institute Founding CEO Dr. Elizabeth Jaffee | Johns Hopkins Kimmel Cancer Center Deputy Director Chapters: 00:02:23 - What is Cancer? 00:04:23 - Stages of Cancer 00:09:21 - Cancer Prevention and Treatment 00:19:34 - Screening Data Disclosure David Rubenstein is a Trustee of Memorial Sloan Kettering Cancer Center David Rubenstein is a Director of Moderna, Inc. David Rubenstein is a Trustee Emeritus of Johns Hopkins Medicine -------- Like this video? Subscribe to The David Rubenstein Show on YouTube:    / @davidrubenstein   Watch the latest episodes of "The David Rubenstein Show: Peer-to-Peer Conversations" here: https://www.bloomberg.com/peer-to-peer Learn more about David: http://www.davidrubenstein.com/ Connect with us on... Twitter:   / business   Facebook:   / bloombergbusiness   Instagram:   / bloombergbusiness